Loading...
NPI 1275597346 · New York, NY · Nuclear Radiology Physician
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Kent Friedman is a nuclear radiology physician provider located in New York, New York. This profile covers 21 Medicare and 1 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Individual |
| Organization | Kent Friedman |
| Address | 560 1st Ave |
| City | New York |
| State | NY |
| ZIP | 10016 |
| Taxonomy | Nuclear Radiology Physician |
| NPI Enumerated | April 14, 2006 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $225.4K |
| Medicaid | $830 |
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
21 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| A9595 | Piflufolastat f-18, diagnostic, 1 millicurie | 160 | $490 | $77.9K |
| 78815 | PET and CT scans are both standard imaging tools that allow doctors to evaluate the location and metabolic actions of tumors or cancer inside the body before beginning an active treatment regimen.… | 240 | $270 | $64.5K |
| 78812 | PET scans are highly effective in the detection of cancerous cells in the body. A PET scan provides a three–dimensional image of the body that makes it easy to detect the presence of a malignant… | 40 | $740 | $32.7K |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 30 | $420 | $14.3K |
| 78816 | The patient is injected with a radiopharmaceutical tracer called FDG (fluoro–deoxyglucose, a radioactive substance containing glucose) about one hour before the imaging is scheduled to begin. The… | 40 | $180 | $6.3K |
| 72197 | In this diagnostic procedure, the provider performs magnetic resonance imaging (MRI) of the pelvis first without using contrast and again after injecting contrast material. | 40 | $150 | $6.1K |
| 99205 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the provider… | 20 | $200 | $4.7K |
| 79101 | In this procedure, the provider injects a radiopharmaceutical substance into the venous blood stream to treat the patient’s condition. | 30 | $80 | $2.5K |
| 78582 | In this diagnostic procedure, the provider performs both pulmonary ventilation and perfusion imaging in a nuclear scan test that evaluates the circulation of air and blood within the patient’s lungs. | 60 | $40 | $2.4K |
| 78306 | The provider performs a bone scan (also known as scintigraphy), a specialized nuclear medicine procedure in which the provider injects a radionuclide prior to imaging to examine the various bones of… | 60 | $30 | $2.1K |
Showing 1–10 of 21
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 21 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
21 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| A9595 | 28 | 50 | 190 | $470 | $251.1K |
| 78815 | 64 | 330 | 80 | $690 | $116.6K |
| A9552 | 140 | 200 | 60 | $350 | $42.8K |
| 78816 | 72 | 140 | 40 | $590 | $31.8K |
| 72197 | 194 | 360 | 50 | $190 | $16.9K |
| 78812 | 3 | 10 | 30 | $320 | $16.1K |
| 99205 | 2,297 | 4,260 | 30 | $180 | $6.4K |
| 78306 | 34 | 170 | 20 | $70 | $3.2K |
| 79101 | 11 | 20 | 30 | $80 | $2.9K |
| 78803 | 14 | 70 | 20 | $90 | $2.8K |
Showing 1–10 of 21
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
1 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 78815 | PET and CT scans are both standard imaging tools that allow doctors to evaluate the location and metabolic actions of tumors or cancer inside the body before beginning an active treatment regimen.… | 30 | $30 | $840 |
How this provider's Medicaid billing volume and revenue compare to other New York providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. New York median
1 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 78815 | PET and CT scans are both standard imaging tools that allow doctors to evaluate the location and metabolic actions of tumors or cancer inside the body before beginning an active treatment regimen.… | 80 | 110 | 80 | $570 | $236.2K |
Other providers in the same ZIP code as Kent Friedman, ranked by combined Medicare and Medicaid revenue.
| Provider | State | Taxonomy | Medicare Revenue | Medicaid Revenue |
|---|---|---|---|---|
| Nyu Langone Hospitals | NY | General Acute Care Hospital | $0 | $238.7M |
| New York City Health And Hospitals Corporation | NY | General Acute Care Hospital | $0 | $176.3M |
| Nyu Langone Hospitals | NY | Oncology Clinic/Center | $0 | $117.7M |
| Alternative Care Systems ,inc | NY | Home Health Agency | $0 | $47.1M |
| Dmitry Khasak | NY | Dermatology Physician | $390.6K | $7.1M |
| Brian Campolattaro | NY | Pediatric Ophthalmology and Strabismus Specialist Physician Physician | $122.7K | $4.2M |
| Morris Nejat | NY | Allergy & Immunology Physician | $260.3K | $2.9M |
| Shane Meehan | NY | Dermatopathology (Pathology) Physician | $1.9M | $4.1K |
| Daniel Kao | NY | Physical Medicine & Rehabilitation Physician | $282.3K | $1.4M |
| Timothy Jayasundera | NY | Cardiovascular Disease Physician | $390K | $962.1K |
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.